Team Blitz India
IN a significant advancement in prenatal care, a hospital in Kerala is revolutionising the detection of genetic diseases within the womb through the introduction of the Next Generation Sequencer (NGS).
This cutting-edge technology will be a cornerstone in the Sabine hospital’s commitment to providing accessible and advanced diagnostic services to the public.
The NGS machine can identify a range of genetic conditions, including various cancers, sickle cell anaemia, haemophilia, Down syndrome, and Turner syndrome early on.
By analysing DNA samples from foetuses, particularly those conceived via IVF treatments, the NGS can pinpoint risk factors and genetic irregularities. The foresight provided by this technology enables healthcare providers to implement preventative measures or begin treatment at the earliest stages so that it mitigates the impact of these conditions postbirth through vigilant testing and monitoring.
This innovative equipment will be installed within Sabine Hospital’s newly inaugurated genetic department, an institution to advance foetal medicine. The hospital has also enhanced its facilities with an upgraded Neonatal Intensive Care Unit (NICU), boasting a 50-bed capacity and a Level 3 NICU rating.
The hospital’s integration of the NGS marks a pivotal step forward in prenatal and neonatal healthcare, promising a future where genetic diseases can be detected and addressed even before birth.
